Paugam-BurtzCKavafyanJMerckxP. Postreperfusion syndrome during LT for cirrhosis: outcome and predictors. Liver Transpl. 2009;15:522-529.
2.
BukowickaBAkarRAOlszewskaAMoterPKrawczykM. The occurrence of postreperfusion syndrome in orthotopic liver transplantation and its significance in terms of complications and short-term survival. Ann Transplant. 2011;16(2):26-30.
3.
MaringJKKlompmakerIJZwavelingJHvan MeerDrLimburgPCSlooffMJ. Endotoxins and cytokines during liver transplantation: changes in plasma levels and effects on clinical outcome. Liver Transpl. 2000;6:480-488.
4.
BezinoverDKadryZMcCulloughP. Release of cytokines and hemodynamic instability during the reperfusion of a liver graft. Liver Transpl. 2011;17:324-330.
5.
HashimotoKEghtesadBGunasekaranG. Use of tissue plasminogen activator in liver transplantation from donation after cardiac death donors. Am J Transplant. 2010;10:2665-2672.
6.
CameronAMGhobrialRMYersizH. Optimal utilization of donor grafts with extended criteria: a single-center experience in over 1000 liver transplants. Ann Surg. 2006;243:748-753.
7.
American Society of Anesthesiologists and the Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography. Practice guidelines for perioperative transesophageal echocardiography. An updated report by the American Society of Anesthesiologists and the Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography. Anesthesiology. 2010;112:1084-1096.
8.
WaxDBTorresAScherCLeibowitzAB. Transesophageal echocardiography utilization in high-volume liver transplantation centers in the United States. J Cardiothora Vasc Anesth. 2008;22:811-813.
BurtenshawAJIsaacJL. The role of trans-oesophageal echocardiography for perioperative cardiovascular monitoring during orthotopic liver transplantation. Liver Transpl. 2006;12:1577-1583.
11.
CareyWDDumotJAPimentelRR. The prevalence of coronary artery disease in liver transplant candidates over age 50. Transplantation. 1995;59:859-864.
12.
De WolfA. Transesophageal echocardiography and orthotopic liver transplantation: general concepts. Liver Transpl Surg. 1999;5:339-340.
13.
HarleyIDJonesEFLiuGMcCallPRMcNicolPL. Orthotopic liver transplantation in two patients with hypertrophic obstructive cardiomyopathy. Br J Anaesth. 1996;77:675-677.
14.
WilliamsJWVeraSPetersTG. Cholestatic jaundice after hepatic transplantation. A nonimmunologically mediated event. Am J Surg. 1986;151:65-70.
15.
KoelzowHGedneyJABaumannJSnookNJBellamyMC. The effect of methylene blue on the hemodynamic changes during ischemia reperfusion injury in orthotopic liver transplantation. Anesth Analg. 2002;94:824-829.
16.
Daemen-GubbelsCRGroeneveldPHGroeneveldABvan KampGJBronsveldWThijsLG. Methylene blue increases myocardial function in septic shock. Crit Care Med. 1995;23:1363-1370.
17.
FischerGWBengtssonYScarolaSCohenE. Methylene blue for vasopressor-resistant vasoplegia syndrome during liver transplantation. J Cardiothorac Vasc Anesth. 2010;24:463-466.
18.
MayerBBrunnerFSchmidtK. Inhibition of nitric oxide synthesis by methylene blue. Biochem Pharmacol. 1993;45:367-374.
19.
MayerBBrunnerFSchmidtK. Novel actions of methylene blue. Eur Heart J. 1993;14(suppl 1):22-26.
20.
HoriNOkanoueTMoriT. Endogenous nitric oxide production is augmented as the severity advances in patients with liver cirrhosis. Clin Exp Pharmacol Physiol. 1996;23:30-35.
21.
SchneiderFLutunPBoudjemaKWolfPTempéJD. In vivo evidence of enhanced guanylyl cyclase activation during the hyperdynamic circulation of acute liver failure. Hepatology. 1994;19:38-44.
22.
LängleFRothESteiningerRWinklerSMühlbacherF. Arginase release following liver reperfusion. evidence of hemodynamic action of arginase infusions. Transplantation. 1995;59(11):1542-9.
23.
IshineNYagiTIshikawaTSasakiHNakagawaKTanakaN. Hemodynamic analysis of post-reperfusion syndrome and the effect of preventing this syndrome using thromboxane A2 synthetase inhibitor (OKY-046) in swine liver transplantation. Transplant Proc. 1997;29:378-381.
24.
BlanotSGillonMCLopezIEcoffwyC. Circulating endotoxins and postreperfusion syndrome during orthotopic liver transplantation. Transplantation, 1995;60:103-106.
25.
MoenchCUhrigALohseAWOttoG. The role of monocyte chemoattractant protein-1 in orthotopic liver transplantation. Transplant Proc. 2003;35:1452-1455.
26.
EnrightSMSrinivasaRBellamyMC. Effect of graft reperfusion on intracellular calcium levels in mononuclear leucocytes during human orthotopic liver transplantation. Br J Surg. 1998;85:673-676.
27.
FrankABonneyMBonneySWeitzelLKoeppenMEckleT. Myocardial ischemia reperfusion injury: from basic science to clinical bedside [published online ahead of print February 23, 2012]. Semin Cardiothorac Vasc Anesth. doi: 10.1177/108925321143635010.1177/1089253211436350
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
